Tag: tumor treating fields

Complement mutation linked to poor response to eculizumab

Tumor Treating Fields vs Standard Therapy in Treatment-Resistant Metastatic NSCLC

byDaniel Goldshteinand1 others

September 25, 2023

1. The median OS was 13.2 months with TTFields arm vs 9.9 months with standard arm, with an HR of ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Prognostic associations of anthropometric indices vary by clinical outcomes
Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

No Result

View All Result

Tag: tumor treating fields

Tumor Treating Fields vs Standard Therapy in Treatment-Resistant Metastatic NSCLC

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits